Department of Neurology and Epileptology, Hertie Institute for Clinical Brain Research, Eberhard Karls University of Tübingen, Tübingen, Germany.
Freiburg Epilepsy Center, Full Member of the ERN EpiCARE, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Germany.
Seizure. 2022 Feb;95:4-10. doi: 10.1016/j.seizure.2021.12.004. Epub 2021 Dec 17.
Genetic testing in people with epilepsy may support presurgical decision-making. It is currently unclear to what extent epilepsy centres use genetic testing in presurgical evaluation.
We performed an exploratory survey among members of the German Society for Epileptology to study the current practice of genetic testing in presurgical evaluation at the respective sites. Survey participants contributed educational case reports.
The majority of participants consider genetic testing to be useful in individuals with familial syndromes or phenotypic features suggesting a genetic etiology. We report 25 cases of individuals with a confirmed genetic diagnosis that have previously undergone epilepsy surgery. Our cases demonstrate that a genetic diagnosis has an impact on both the decision-making process during presurgical evaluation, as well as the postoperative outcome.
Genetic testing as part of the presurgical work-up is becoming increasingly established in epilepsy centres across Germany. mTORopathies and genetic hypothalamic hamartomas seem to be associated with a generally favourable surgical outcome. Synaptopathies and channelopathies may be associated with a worse outcome and should be considered on a case-by-case level. Prospective studies are needed to examine the impact of an established genetic diagnosis on postsurgical outcome.
对癫痫患者进行基因检测有助于术前决策。目前尚不清楚癫痫中心在术前评估中基因检测的应用程度。
我们对德国癫痫学会的成员进行了一项探索性调查,以研究各中心在术前评估中进行基因检测的当前情况。调查参与者提供了教育病例报告。
大多数参与者认为基因检测对于家族性综合征或具有遗传病因提示的表型特征的个体是有用的。我们报告了 25 例经证实的基因诊断患者,这些患者之前已接受过癫痫手术。我们的病例表明,基因诊断对术前评估过程中的决策以及术后结果都有影响。
基因检测作为术前评估的一部分,在德国的癫痫中心越来越普及。mTOR 病变和遗传下丘脑错构瘤似乎与总体良好的手术结果相关。突触病和通道病可能与较差的结果相关,应根据具体情况进行考虑。需要前瞻性研究来检查既定基因诊断对术后结果的影响。